Follow
Dhanaji Lade
Title
Cited by
Cited by
Year
Cobalt (iii)-catalyzed C–H halogenation of 6-arylpurines: facile entry into arylated, sulfenylated and alkoxylated 6-arylpurines
AB Pawar, DM Lade
Organic & Biomolecular Chemistry 14 (12), 3275-3283, 2016
712016
Cp* Co (III)-catalyzed vinylic C–H bond activation under mild conditions: expedient pyrrole synthesis via (3+ 2) annulation of enamides and alkynes
DM Lade, AB Pawar
Organic Chemistry Frontiers 3 (7), 836-840, 2016
562016
Cp* Co (III)-Catalyzed C–H/N–N Functionalization of Arylhydrazones for the Synthesis of Isoquinolines
AB Pawar, D Agarwal, DM Lade
The Journal of Organic Chemistry 81 (22), 11409-11415, 2016
532016
Cp* Ir (III)-catalyzed C–H/N–H functionalization of sulfoximines for the synthesis of 1, 2-benzothiazines at room temperature
YN Aher, DM Lade, AB Pawar
Chemical communications 54 (49), 6288-6291, 2018
502018
Total synthesis of lamellarin D trimethyl ether, lamellarin D, and lamellarin H
DM Lade, AB Pawar, PS Mainkar, S Chandrasekhar
The Journal of Organic Chemistry 82 (9), 4998-5004, 2017
502017
Strategies towards the synthesis of anti-tuberculosis drugs
HB Rode, DM Lade, R Grée, PS Mainkar, S Chandrasekhar
Organic & Biomolecular Chemistry 17 (22), 5428-5459, 2019
302019
Cp* Ir (III)-Catalyzed C–H/O–H Functionalization of Salicylaldehydes for the Synthesis of Chromones at Room Temperature
DM Lade, YN Aher, AB Pawar
The Journal of Organic Chemistry 84 (14), 9188-9195, 2019
282019
A Facile synthesis and antituberculosis properties of almazole D and its enantiomer
DM Lade, VS Krishna, D Sriram, HB Rode
ChemistrySelect 2 (3), 1250-1252, 2017
152017
Design and synthesis of improved active-site SHP2 inhibitors with anti-breast cancer cell effects
DM Lade, R Nicoletti, J Mersch, YM Agazie
European Journal of Medicinal Chemistry 247, 115017, 2023
22023
Targeting SHP2 with an Active Site Inhibitor Blocks Signaling and Breast Cancer Cell Phenotypes
DM Lade, YM Agazie
ACS bio & med Chem Au 3 (5), 418-428, 2023
2023
The system can't perform the operation now. Try again later.
Articles 1–10